References
- Wilson W H, Jamis-Dow C, Bryant G, et al. Phase I and pharmacokinetic study of the multidrug resistance modulator dexvera-pamil with EPOCH chemotherapy. J Clin Oncol 1995; 13: 1985–1994
- Wilson W H, Bates S E, Fojo A, et al. Controlled trial of dexver-apamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. J Clin Oncol 1995; 13: 1995–2004
- Molldrem J, Wilson W H. Infusional chemotherapy for non-Hodg-kin's lymphoma. Cancer Invest 1997; 15: 465–474
- Wilson W H, Chabner B A. Principles of chemotherapy for lymphomas. The Lymphomas, G P Canellos, T A Lister, J L Sklar. Saunders W.B., Philadelphia 1998; 235–245
- Sparano J A, Wiernik P H, Hu X, et al. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 3026–3035
- Friedenberg W R, Anderson J, Wolf B C, et al. Modified vincristine. doxorubicin, and dexamefhasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group Study. Cancer 1993; 71: 2983–2989
- Alexanian R, Barlogie B, Tucker S. VAD-based regimens as primary treatment for multiple myeloma. Am J Hematol 1990; 33: 86–89
- Kantarjian H M, Walters R S, Keating M J, et al. Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocyte leukemia. Cancer 1989; 64: 16–22
- Walters R S, Kantarjian H M, Keating M J, et al. Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron. Cancer 1987; 60: 1708–1712
- Anderson H, Scarffe J H, Lambert M, et al. VAD chemotherapy– toxicity and efficacy–in patients with multiple myeloma and other lymphoid malignancies. Hematol Oncol 1987; 5: 213–222
- Barlogie B, Smith L, Alexanian R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med 1984; 310: 1353–1356